Herantis Pharma to Participate in the Upcoming Investor Conferences
Herantis Pharma Plc, Press Release, 29 September 2021 at 12:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and have a company presentation at the following investor conferences: Sachs 21[st] Annual Biotech in Europe Forum, October 7[th] - 8[th], 2021, Digital Conference 1x1 meetings and virtual presentation Redeye Neurology Seminar CNS – October 13[th], 2021 Virtual Presentations at 10:00 – 13:00 EEST / 9:00 – 12: